Last Updated on February 26, 2023 by The Health Master
In the Budget 2023, Union Finance Minister Nirmala Sitharaman allotted Rs 1,250 crore for the development of bulk drug parks and the promotion of medical device parks in the country.
“The allocation of Rs 1,250 has been for the development of bulk drug parks and for the promotion of medical device parks in the country.”
It includes Rs 1,000 crore for bulk drug parks, and Rs 200 Promotion of medical device parks,” an official from the Department of Pharmaceutical told.
The allocations for developing the bulk drug and medical device parks have seen a record rise of over 1150 percent.
Last year, the Center had allocated only Rs 100 crore for developing the bulk drug and medical device parks.
The Centre has previously said that the department of pharmaceuticals would implement the scheme “Promotion of Medical Device Parks” to create a world-class infrastructure to make the Indian medical device industry a global leader.
“The scheme for the promotion of Bulk Drug Parks’, has a financial outlay of Rs. 3,000 crores from FY 2020–2021 to FY 2024–25.”
“This scheme provides financial assistance to three states for establishing Bulk Drug Parks,” Bhagwanth Khuba, Minister of State for Chemicals and Fertilizers, told the Lok Sabha last year.
The minister had said that the total financial outlay of “Promotion of Medical Devices Parks” was Rs 400 crore and the maximum assistance under the scheme for a medical device park would be limited to Rs 100 crore.
In her budget speech, Sitharaman also announced that the Center will bring a new program to promote research and innovation in the pharmaceutical sector, which will be taken up through centers of excellence in the country.
“A new program to promote research and innovation in the pharma sector will be taken up through centers of excellence.”
“We shall also encourage industry to invest in research and development in specific priority areas,” Sithraman said.
When asked about the fund allocations for promoting research and innovation in the pharma sector, the official said it would be done after the cabinet approves the proposal.
“The matter of promoting research and innovation in the pharma sector would be first approved by the cabinet, and then an allocation for the same would be done from the health ministry,” the official added.
NSQ Drug: Route cause analysis and CAPA
USFDA gives nod for Technetium Mertiatide Injection
New programme to promote research in Pharma Industry
DCGI allows relabeling & re-stickering of drugs: Rule 104A
USFDA tentative nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide tablets
Light sensitive drugs / medicines: List
PowerPoint Slide Shows for Regulators and Industry
Area required for manufacturing of Drugs, Cosmetics, Homoeopathic & Blood Centre
BA / BE Studies: Bioavailability & Bioequivalence
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
